Trump Administration Says It's Not Looking to Take Stakes in TSMC, Micron

A Trump administration official has clarified that the U.S. government is not seeking equity stakes from Taiwan Semiconductor Manufacturing Company (TSMC) or Micron (MU) in exchange for CHIPS Act grants, despite earlier comments from Commerce Secretary Howard Lutnick suggesting such demands. This contrasts with Intel, which might be more amenable to such terms given its turnaround efforts, while TSMC has reportedly indicated it would return funding if equity were required. The clarification appears to have positively impacted investor sentiment, with shares of TSMC and Micron climbing approximately 3% in recent trading, signaling market relief over the grant terms.

Analysis

A recent clarification from a Trump administration official indicates that Taiwan Semiconductor Manufacturing Company (TSM) and Micron (MU) will likely not be required to grant equity stakes in exchange for CHIPS Act funding. This development removes a significant uncertainty for both companies, whose shares subsequently climbed approximately 3%, a move also supported by a broader market rally following dovish signals from the Federal Reserve. The situation for TSM and MU contrasts sharply with that of Intel (INTC), which is portrayed as being in a weaker negotiating position due to its ongoing turnaround efforts, including headcount reductions and asset sales. Analyst commentary suggests that TSM and MU possess the leverage to outright reject such terms, with TSMC reportedly willing to return its funding rather than accept the U.S. government as a stockholder. The divergence in potential CHIPS Act terms underscores the differing fundamental strengths of the companies, with the market reacting positively to the reduced dilution risk for TSM and MU, while reflecting continued concern for Intel's more challenged circumstances.

Key Decisions for Investors

• For investors in TSM and MU, the removal of the equity-for-grant requirement de-risks their U.S. expansion projects and reduces the threat of shareholder dilution, reinforcing the bullish case for their participation in the CHIPS Act.
• Investors in Intel should monitor for potential dilutive financing terms related to its CHIPS Act grant, as the company's weaker position relative to peers could force it to accept a less favorable equity stake agreement.
• The conflicting comments from administration officials and political figures highlight a tangible political risk; investors should consider that the terms of these government grants could be revisited or altered depending on future election outcomes.